Growth Hormone-Releasing Hormone Analogues Show Anti-Anxiety and Antidepressant Effects in Mice
Both a GHRH antagonist and agonist reduced anxiety and depression-like behavior in mice, while decreasing brain inflammation, boosting serotonin and norepinephrine, and activating antioxidant pathways.
Quick Facts
What This Study Found
Both MIA-690 (antagonist) and MR-409 (agonist) produced anxiolytic and antidepressant-like effects, increased monoamine neurotransmitters, decreased NF-κB/TNF-α/IL-6, and increased Nrf2 expression in mouse prefrontal cortex, with MIA-690 showing higher anti-inflammatory efficacy.
Key Numbers
5 mcg/day for 4 weeks; increased NE and serotonin; decreased NF-kB, TNF-α, IL-6; increased Nrf2; MIA-690 stronger anti-inflammatory
How They Did This
Ex vivo: tested both compounds on LPS-treated mouse prefrontal cortex specimens for anti-inflammatory and antioxidant effects. In vivo: chronic treatment of mice followed by behavioral testing for anxiety and depression, with brain tissue analysis for neurotransmitters, inflammatory markers, and gene expression.
Why This Research Matters
GHRH analogues were developed as anti-cancer agents, but these brain effects suggest they could have unexpected therapeutic potential for neuropsychiatric conditions involving inflammation and oxidative stress.
The Bigger Picture
This study adds to growing evidence that growth hormone-related peptides have significant neuromodulatory effects beyond endocrine function, potentially opening new treatment avenues for mood disorders with inflammatory components.
What This Study Doesn't Tell Us
Mouse study — behavioral tests may not translate to human psychiatric conditions. Mechanism of anxiolytic/antidepressant action not fully defined. Surprising that both agonist and antagonist produce similar behavioral effects. Sample sizes not reported.
Questions This Raises
- ?Why do both GHRH agonist and antagonist produce similar behavioral effects despite opposing endocrine actions?
- ?Could GHRH analogues be developed specifically for neuropsychiatric indications?
- ?Do these compounds affect other brain regions involved in mood regulation beyond the prefrontal cortex?
Trust & Context
- Key Stat:
- Both agonist & antagonist worked Paradoxically, both GHRH agonist MR-409 and antagonist MIA-690 produced anxiolytic and antidepressant effects in mice
- Evidence Grade:
- Preliminary — mouse behavioral and molecular data suggesting novel brain effects of GHRH analogues, with no human psychiatric data.
- Study Age:
- Published in 2020; the neuropsychiatric potential of GHRH analogues remains largely unexplored clinically.
- Original Title:
- Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice.
- Published In:
- Scientific reports, 10(1), 732 (2020)
- Authors:
- Recinella, Lucia(5), Chiavaroli, Annalisa(5), Orlando, Giustino(5), Ferrante, Claudio, Marconi, Guya Diletta, Gesmundo, Iacopo, Granata, Riccarda, Cai, Renzhi, Sha, Wei, Schally, Andrew V, Brunetti, Luigi, Leone, Sheila
- Database ID:
- RPEP-05090
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is GHRH and what are its analogues used for?
Growth hormone-releasing hormone normally stimulates growth hormone release from the pituitary. Synthetic GHRH analogues (both stimulators and blockers) were developed primarily as anti-cancer agents, but this study reveals they also affect brain function.
How might these compounds help with anxiety and depression?
They appear to work through multiple mechanisms: boosting mood-regulating neurotransmitters (serotonin, norepinephrine), reducing brain inflammation, and activating antioxidant defenses — all factors linked to anxiety and depression.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-05090APA
Recinella, Lucia; Chiavaroli, Annalisa; Orlando, Giustino; Ferrante, Claudio; Marconi, Guya Diletta; Gesmundo, Iacopo; Granata, Riccarda; Cai, Renzhi; Sha, Wei; Schally, Andrew V; Brunetti, Luigi; Leone, Sheila. (2020). Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice.. Scientific reports, 10(1), 732. https://doi.org/10.1038/s41598-019-57292-z
MLA
Recinella, Lucia, et al. "Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice.." Scientific reports, 2020. https://doi.org/10.1038/s41598-019-57292-z
RethinkPeptides
RethinkPeptides Research Database. "Antinflammatory, antioxidant, and behavioral effects induced..." RPEP-05090. Retrieved from https://rethinkpeptides.com/research/recinella-2020-antinflammatory-antioxidant-and-behavioral
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.